Wenbo Zhu

9PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 07, 2026
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1+CD8+ T cells.

|Jul 01, 2026
Alphavirus M1 disrupts super-enhancer-driven oncogenic transcription via non-structural protein NSP2 in osteosarcoma.

|Nov 14, 2025
TAMs-mediated resistance to oncolytic virus M1 in solid tumors.

Xuanming Liang, Jingjie Li, Jiehong Chen

|Aug 11, 2025
Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma.

Chan Xie, Xingrong Zheng, Songmin He

|Jul 03, 2025
Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction.

Zhen Fan, Ying Liu, Xueying Lin

|Oct 20, 2023
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1.

Deli Song, Xudong Jia, Yuanzhu Gao

Pageof 2

Frequent Collaborators

6 joint publications

Yuan Lin

5 joint publications

Jiankai Liang

3 joint publications

Ke Sai

3 joint publications

Guangmei Yan